Lilly’s Mounjaro receives FDA approval for type 2 diabetes treatment

Status
Not open for further replies.

Amity Island

Well-Known Member
Relationship to Diabetes
Type 1
The US Food and Drug Administration (FDA) has granted approval for Eli Lilly and Company’s Mounjaro (tirzepatide) injection as an adjunct to diet and exercise to enhance glycemic control in adult patients with type 2 diabetes.

 
Status
Not open for further replies.
Back
Top